These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25304109)

  • 1. Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.
    Luque-Ramírez M; Escobar-Morreale HF
    Curr Hypertens Rep; 2014 Dec; 16(12):500. PubMed ID: 25304109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.
    Lazaridou S; Dinas K; Tziomalos K
    Hormones (Athens); 2017 Oct; 16(4):373-380. PubMed ID: 29518757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched-chain amino acids as a novel biomarker of metabolic disturbances in women with polycystic ovary syndrome - literature review.
    Szmygin H; Lenart-Lipinska M; Szydelko J; Wozniak S; Matyjaszek-Matuszek B
    Ginekol Pol; 2022; 93(8):665-669. PubMed ID: 35942720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic risks in PCOS: a review of the current state of knowledge.
    Kakoly NS; Moran LJ; Teede HJ; Joham AE
    Expert Rev Endocrinol Metab; 2019 Jan; 14(1):23-33. PubMed ID: 30556433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.
    Mirzaei F; Kazemi N
    Metab Syndr Relat Disord; 2008 Sep; 6(3):215-7. PubMed ID: 18710333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.
    Reyes-Muñoz E; Ortega-González C; Martínez-Cruz N; Arce-Sánchez L; Estrada-Gutierrez G; Moran C; Sánchez-Serrano AP; Higareda-Sánchez R; de la Jara-Díaz JF
    BMJ Open; 2016 Jul; 6(7):e012107. PubMed ID: 27449893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovarian syndrome.
    Khan KA; Stas S; Kurukulasuriya LR
    J Cardiometab Syndr; 2006; 1(2):125-30; quiz 131-2. PubMed ID: 17679815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice.
    Nohara K; Waraich RS; Liu S; Ferron M; Waget A; Meyers MS; Karsenty G; Burcelin R; Mauvais-Jarvis F
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1321-30. PubMed ID: 23612996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of undiagnosed Prediabetes/type 2 diabetes, prehypertension/hypertension and obesity among ethnic groups of adolescents in Western Canada.
    Spurr S; Bally J; Bullin C; Allan D; McNair E
    BMC Pediatr; 2020 Jan; 20(1):31. PubMed ID: 31973728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
    Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
    Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
    Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
    J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic.
    Leon G; de Klerk E; Ho J; Jackman M; Reimer RA; Connors KE; Luca P
    J Pediatr Endocrinol Metab; 2018 Mar; 31(4):385-390. PubMed ID: 29432207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors.
    Pruett JE; Romero DG; Yanes Cardozo LL
    Front Endocrinol (Lausanne); 2023; 14():951099. PubMed ID: 36875461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
    Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.
    Torchen LC
    Curr Diab Rep; 2017 Nov; 17(12):137. PubMed ID: 29128916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.